Standout Papers
Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Telehealth and patient satisfaction: a systematic review and narrative analysis
2017 Standout
Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology
2015 Standout
Digitalization to achieve sustainable development goals: Steps towards a Smart Green Planet
2021 Standout
Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials
2014
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
2015
Universal Definition of Myocardial Infarction: Clinical Insights
2015 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Gender Differences in Acute Non–ST-Segment Elevation Myocardial Infarction
2006
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
2014
Sarcopenia: a chronic complication of type 2 diabetes mellitus
2018 Standout
The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies – The Cardiac Rehabilitation Outcome Study (CROS)
2016
Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health
2020
Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis
2012
Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis
2013
Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial
2008
Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
2017 StandoutNobel
Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment
2010
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era
2010
Heparin and Low-Molecular-Weight Heparin
1998
Recommendations for the use of natriuretic peptides in acute cardiac care: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care
2011
Heparin-induced thrombocytopenia and cardiac surgery
2003 Standout
Door-to-Balloon Times Under 90 Min Can Be Routinely Achieved for Patients Transferred for ST-Segment Elevation Myocardial Infarction Percutaneous Coronary Intervention in a Rural Setting
2011
Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention
2010
Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era
2006
Atherosclerosis
2019 Standout
From rapalogs to anti-aging formula
2017
Impact of bivalirudin on in‐hospital bleeding and six‐month outcomes in octogenarians undergoing percutaneous coronary intervention
2009
Type 2 diabetes mellitus
2015 Standout
2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Age-related differences in diagnosis, treatment and outcome of acute coronary syndromes: results from the German ALKK registry
2012
Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention
2009
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases
2018
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Combination therapy in dyslipidemia: Where are we now?
2014
Prevalence and pattern of dyslipidaemia in type 2 diabetes mellitus patients at a tertiary care hospital
2017
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes
2020 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Mobile health solutions for the aging population: A systematic narrative analysis
2016
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
The digital revolution and its impact on mental health care
2019
ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation
2012
Works of Claus Jünger being referenced
Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany
2010
Effect of Chronic Statin Pretreatment on Hospital Outcome in Patients With Acute Non-ST-Elevation Myocardial Infarction
2009
Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service – results from the prospective, multi-center, observational cohort study thrombEVAL
2015
Persistent lipid abnormalities in statin‐treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study
2011
Do statins influence the prognostic impact of non-sustained ventricular tachycardia after ST-elevation myocardial infarction?
2005
Influence of presentation at the weekend on treatment and outcome in ST-elevation myocardial infarction in hospitals with catheterization laboratories
2008
Loneliness in the general population: prevalence, determinants and relations to mental health
2017 Standout
Relative Role of NT-pro BNP and Cardiac Troponin T at 96 hours for Estimation of Infarct Size and Left Ventricular Function After Acute Myocardial Infarction
2007
Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention
2009
Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction
2007
Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction
2007
Clinical Benefit of Enoxaparin in Patients With High-Risk Acute Coronary Syndromes Without ST Elevations in Clinical Practice
2006
Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach
2011
Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada
2011
Effect of early short-term cardiac rehabilitation after acute ST-elevation and non-ST-elevation myocardial infarction on 1-year mortality
2010